Bruce Jackson
Stock Analyst at Benchmark
(1.34)
# 3,317
Out of 4,711 analysts
115
Total ratings
35.96%
Success rate
-14.13%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLNN Clene | Maintains: Buy | $90 → $84 | $4.40 | +1,809.09% | 7 | Nov 22, 2024 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.68 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.68 | +338.60% | 8 | Nov 22, 2024 | |
| MLSS Milestone Scientific | Reiterates: Speculative Buy | $1.25 | $0.93 | +34.41% | 2 | Nov 20, 2024 | |
| BFRI Biofrontera | Reiterates: Buy | $7 | $0.98 | +615.38% | 7 | Nov 15, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $67 → $65 | $59.40 | +9.43% | 6 | Nov 6, 2024 | |
| HOTH Hoth Therapeutics | Reiterates: Speculative Buy | $3 | $0.81 | +270.37% | 3 | Oct 11, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $4.64 | +223.28% | 12 | Oct 10, 2024 | |
| GDTC CytoMed Therapeutics | Reiterates: Speculative Buy | $5 | $2.56 | +95.31% | 4 | Oct 10, 2024 | |
| NEO NeoGenomics | Reiterates: Buy | $18 | $16.41 | +9.69% | 6 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $5.65 | +430.97% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $2 | $0.97 | +105.38% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $1.34 | +1,168.66% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.84 | +1,204.35% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $64.12 | -11.10% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $25 | $2.27 | +1,001.32% | 6 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $0.14 | +614.29% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.19 | +128.31% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.39 | +259.71% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.46 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.82 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $7 | $2.11 | +231.75% | 4 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.83 | +20,787.73% | 1 | Aug 8, 2022 |
Clene
Nov 22, 2024
Maintains: Buy
Price Target: $90 → $84
Current: $4.40
Upside: +1,809.09%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.68
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.68
Upside: +338.60%
Milestone Scientific
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.93
Upside: +34.41%
Biofrontera
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.98
Upside: +615.38%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $67 → $65
Current: $59.40
Upside: +9.43%
Hoth Therapeutics
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.81
Upside: +270.37%
Humacyte
Oct 10, 2024
Reiterates: Buy
Price Target: $15
Current: $4.64
Upside: +223.28%
CytoMed Therapeutics
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.56
Upside: +95.31%
NeoGenomics
Sep 24, 2024
Reiterates: Buy
Price Target: $18
Current: $16.41
Upside: +9.69%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $5.65
Upside: +430.97%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.97
Upside: +105.38%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $1.34
Upside: +1,168.66%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.84
Upside: +1,204.35%
Aug 13, 2024
Reiterates: Buy
Price Target: $57
Current: $64.12
Upside: -11.10%
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $25
Current: $2.27
Upside: +1,001.32%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $0.14
Upside: +614.29%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.19
Upside: +128.31%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.39
Upside: +259.71%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.46
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $24.82
Upside: -
Jun 22, 2023
Reiterates: Speculative Buy
Price Target: $7
Current: $2.11
Upside: +231.75%
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.83
Upside: +20,787.73%